Executive Insights

Monogram Orthopedics seeks to personalize joint replacement through a combination of innovative implants and robotics....

The oversubscribed $12.5 million Series D round sets Catalyst to expand product lines and build out its infrastructure to support...

While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC...

Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations....

Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact....

The differences between the hospital and ASC setting are vast and present a learning curve for those managing, operating in...

As businesses mature and seek to expand, exporting may become a viable option. Introducing new or existing products to other...

OMTEC held a keynote that delved into the state of the orthopedic market and what lies ahead for volumes and...

Mr. Lin has led the U.S. operations for United Orthopedic for more than a decade. He has learned that trust...

These companies recently received notable FDA 510(k) clearances, funding or launched products and studies. We highlight robotics/digital, spine and orthobiologic...